Atlas Lithium

Atlas Lithium made $121K last year and still traded at a $132M market cap.

If you own ATLX, you own a Brazil mining bet with almost no sales.

atlx

materials · lithium small cap updated mar 6, 2026
$4.99
market cap ~$132M · 52-week range $4–$8
xvary composite: 41 / 100 · below average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
Atlas Lithium hunts for lithium and other battery minerals in Brazil, and owns 35% of Jupiter Gold.
how it gets paid
Last year Atlas Lithium made $121K in revenue.
why growth slowed
Revenue fell 83.8% last year. The $79K quarterly revenue number mattered most because it shows how little cash the business is actually pulling in.
what just happened
Atlas Lithium posted $79K of quarterly revenue; gross margin is n/m at this revenue scale.
At a glance
C++ balance sheet — some cracks in the foundation
-$2.91 fy2024 eps est
~$121K reported FY revenue
n/m operating margin — revenue too small for a clean %
1.55 beta
xvary composite: 41/100 — below average
What they do
Atlas Lithium hunts for lithium and other battery minerals in Brazil, and owns 35% of Jupiter Gold.
You are buying 539 km² of lithium land and 85 mineral rights, meaning legal claims to dig, in Brazil. That is 539 km² against $121K of annual sales. It also owns 35% of Jupiter Gold, but the real story is still the dirt.
materials micro-cap lithium mining brazil
How they make money
$121K annual revenue · revenue declined -83.8% last year
total revenue
$121K
83.8%
The products that matter
lithium exploration and development
neves project
$92K tied to mineral property revenue
this is the asset carrying the $132M equity story. if neves reaches commercial production in 2026, the thesis survives. if it slips, the story gets repriced fast.
core asset
brazil mineral rights portfolio
mineral exploration rights
$29K other revenue
these rights are the option value. for now, they support a business that produced only $121K of total revenue, which tells you how early this still is.
option value
Key numbers
$121K
annual sales
That is 1,091x smaller than the $132M market cap.
$132M
market cap
You are paying $132M for $121K of annual sales.
$10M
debt
Debt equals 7% of capital, which matters when sales are only $121K.
n/m
operating margin
With ~$121K FY sales, feed-style margin percentages are meaningless. Focus on cash burn and project timeline, not a giant bogus %.
Financial health
C++
strength
  • balance sheet grade C++ — below average — limited financial resources
  • risk rank 3 — safer than 50% of stocks
  • price stability 5 / 100
  • long-term debt $10M (7% of capital)
C++ — below average. watch for debt servicing and cash burn.
Total return vs. market

Return history isn't available for ATLX right now.

source: institutional data · return history unavailable
What just happened
missed estimates
Atlas Lithium posted $79K of quarterly revenue; gross margin is n/m at this scale.
FY revenue fell 83.8% to $121K on the annual line above. The ~$79K figure here is the latest quarter (compare vs. prior year in filings — do not read “flat” as contradicting the full-year decline). EPS was -$1.18.
$79K
revenue (Q)
-$1.18
eps (Q)
n/m
gross margin
the number that mattered
The $79K quarterly revenue number mattered most because it shows how little cash the business is actually pulling in.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the #1 risk is missing the 2026 neves project production target.

med
the mine arrives late or not at all
the current equity story assumes neves becomes a commercial lithium operation by 2026. pre-production miners do not get many timeline misses before the market starts pricing the asset as a concept instead of a business.
impact: the gap between a $132M market cap and $121K of revenue stops looking like ambition and starts looking like overpayment.
med
valuation compression
ATLX trades at 167x sales versus a 4.3x sector average. that premium survives only while investors believe the future revenue jump is plausible and near enough to matter.
impact: even decent project progress can fail to save the stock if the market decides to pay a normal multiple instead of a dream multiple.
med
financing pressure
C++ balance sheet grade, a -$2.91 eps estimate, and $10M of long-term debt tell you this business is still in cash-out mode. delays increase the odds that outside capital arrives on worse terms.
impact: shareholders can end up funding the wait while the project remains pre-production.
med
disclosure and control scrutiny
a 2024 SEC document referenced the risk of not detecting a material misstatement from fraud. that does not prove wrongdoing. it does raise the standard of proof the company needs to meet with investors.
impact: credibility discounts can stick around longer than operational ones, especially in small-cap resource stories.
this is a $132M equity story resting on $121K of trailing revenue, a 2026 production target, and a valuation that already assumes the hard part works.
source: institutional data · regulatory filings · risk analysis
Pay attention to
catalyst
2026 first-production target
this is the main date in the entire story. if the timeline slips, the stock needs a new valuation logic.
metric
revenue leaving the five-figure zone
$121K of trailing revenue cannot justify a $132M story by itself. you want evidence of commercial sales, not just project language.
risk
balance sheet pressure
C++ balance sheet grade and $10M of long-term debt mean every quarter without production makes financing more important.
trend
multiple compression vs. the sector
167x sales against a 4.3x sector average leaves very little room for patience. if sentiment cools, the multiple can fall faster than the project advances.
Analyst rankings
risk profile
average
risk rank 3 — typical risk profile — neither especially safe nor risky.
chart momentum
below average
momentum rank 4 — analysts see underperformance risk in the near term.
source: institutional data
Institutional activity

institutional ownership data for ATLX is being compiled.

source: institutional data
Price targets
3-5 year target range
n/a n/a
$5 current price
n/a target midpoint · n/a from current
target data not available

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
ATLX
xvary deep dive
atlx
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it